Roche Holding AG (LON:0QQ6)
London
· Delayed Price · Currency is GBP · Price in CHF 275.80
+0.80 (0.29%)
At close: Jul 1, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
Roche Pharmaceuticals | 43.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Roche Pharmaceuticals Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Chugai | 2.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Chugai Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics | 14.32B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Growth | 0.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
Other | -5.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Roche Pharmaceuticals Capital Expenditures | 6.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Roche Pharmaceuticals Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Chugai Capital Expenditures | 350.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Chugai Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Capital Expenditures | 2.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Capital Expenditures | 78.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -5.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -5.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -5.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
Other | 6.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 6.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Roche Pharmaceuticals Operating Profit | 12.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Roche Pharmaceuticals Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Chugai Operating Profit | 3.21B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Chugai Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Operating Profit | 1.95B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Operating Profit | -4.12B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 6.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 6.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
Other | 1.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Switzerland | 747.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Switzerland Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Germany | 2.93B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Germany Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of Europe | 10.29B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 28.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of North America | 889.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of North America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Latin America | 3.25B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Latin America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan | 3.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of Asia | 9.09B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa, Australia and Oceania | 1.25B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa, Australia and Oceania Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|